Clinical trial
Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive…
NCT00279019 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00279019 |
|---|---|
| Title | Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease |
| Official title | A Randomised, Double Blind, Placebo-controlled, Double Dummy, 4-way Cross-over, Dose Ascending Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Inhaled Doses of GSK233705 and Tiotropium Bromide (18µg) Via DPI in COPD Patients |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | GSK233705, Tiotropium, Placebo |
| Enrollment | 31 |
| Start date | Dec 12, 2005 |
| Primary completion | Jun 13, 2006 |
| Completion | Jun 13, 2006 |
| First posted | Jan 19, 2006 |
| Last update posted | Sep 25, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: